J. Beleta

发表

The human area postrema and other nuclei related to the emetic reflex express cAMP phosphodiesterases 4B and 4D

J. Palacios, G. Mengod, A. Gavaldá, 2010, Journal of Chemical Neuroanatomy.

Resident Cell Chemokine Expression Serves as the Major Mechanism for Leukocyte Recruitment During Local Inflammation

E. García-Ramallo, S. Kunkel, N. Prats, 2002, The Journal of Immunology.

Second messenger systems as targets for new therapeutic agents: focus on selective phosphodiesterase inhibitors.

J. Palacios, V. Segarra, J. Beleta, 1995, Farmaco.

Anticholinergic effects of desloratadine, the major metabolite of loratadine, in rabbit and guinea-pig iris smooth muscle.

J. Palacios, J. Beleta, J M Palacios, 1999, European journal of pharmacology.

Phosphodiesterase inhibitory properties of losartan. Design and synthesis of new lead compounds.

V. Segarra, J. Palacios, J. Beleta, 1998, Bioorganic & medicinal chemistry letters.

Brain pyruvate oxidation in experimental thiamin-deficiency encephalopathy.

F. González-Sastre, J. Beleta, J. Beleta, 1996, Clinica chimica acta; international journal of clinical chemistry.

Synthesis and biological evaluation of a conformationally free seco-analogue of the immunosuppressant FR901483.

L. Santamaria, V. Segarra, H. Ryder, 1999, Bioorganic & medicinal chemistry.

Purification and characterization of two phosphorylase phosphatases from rabbit liver.

J. Beleta, F. Gella, P. Benedicto, 1987, The International journal of biochemistry.

Identification and characterization of serotonin 5-HT4 receptor binding sites in human brain: comparison with other mammalian species.

E. Tolosa, J. Palacios, J. Beleta, 1994, Brain research. Molecular brain research.

Recruitment During Local Inflammation as the Major Mechanism for Leukocyte Resident Cell Chemokine Expression Serves

S. Kunkel, J. Beleta, N. Godessart, 2002 .

Efficacy And Safety Of Aclidinium Bromide 400 μg BID Compared With Placebo And Tiotropium In Patients With Moderate To Severe COPD

J. Cortijo, H. Ryder, J. Beleta, 2022 .

Pharmacological blockade of CCR1 ameliorates murine arthritis and alters cytokine networks in vivo

S. Kunkel, N. Prats, J. Beleta, 2006, British journal of pharmacology.

Benzyl derivatives of 2,1,3-benzo- and benzothieno[3,2-a]thiadiazine 2,2-dioxides: first phosphodiesterase 7 inhibitors.

J. Casacuberta, V. Segarra, H. Ryder, 2000, Journal of medicinal chemistry.

Rolipram inhibits staphylococcal enterotoxin B-mediated induction of the human skin-homing receptor on T lymphocytes.

A. Giménez-Arnau, H. Ryder, J. Palacios, 1999, The Journal of investigative dermatology.

Purification and characterization of streptolysin O from Streptococcus pyogenes.

F. González-Sastre, J. Beleta, J. Beleta, 1992, The International journal of biochemistry.

Enzymatic determination of anti-NAD+ glycohydrolase in serum.

F. González-Sastre, J. Beleta, F. Gella, 1993, Clinical chemistry.

Purification and characterization of native and proteolytic forms of rabbit liver phosphorylase kinase.

J. Beleta, P. Aymerich, F. Gella, 1990, The International journal of biochemistry.

Regulatory properties of rabbit liver phosphorylase kinase.

J. Beleta, F. Gella, P. Benedicto, 1990, The International journal of biochemistry.

Synthesis and biological evaluation of 3,4-diaryloxazolones: A new class of orally active cyclooxygenase-2 inhibitors.

V. Segarra, H. Ryder, J. Palacios, 2000, Journal of medicinal chemistry.

Synthesis and biological evaluation of 2-phenylpyran-4-ones: a new class of orally active cyclooxygenase-2 inhibitors.

F. Caturla, H. Ryder, J. Beleta, 2004, Journal of medicinal chemistry.

Design, synthesis, and biological activities of new thieno[3,2-d] pyrimidines as selective type 4 phosphodiesterase inhibitors.

V. Segarra, H. Ryder, J. Palacios, 1998, Journal of medicinal chemistry.

Lymphocyte phosphorylase kinase.

J. Beleta, F. Javier Gella, E. Concustell, 1981, The International journal of biochemistry.

Selective induction of cyclo‐oxygenase‐2 activity in the permanent human endothelial cell line HUV‐EC‐C: biochemical and pharmacological characterization

J. López-Belmonte, J. Beleta, M. Miralpeix, 1997, British journal of pharmacology.

Synthesis and biological evaluation of 2,5-dihydropyrazolo[4,3-c]quinolin-3-ones, a novel series of PDE 4 inhibitors with low emetic potential and antiasthmatic properties

V. Segarra, H. Ryder, J. Palacios, 2000 .

Purification of several proteins involved in glycogen metabolism.

J. Beleta, F. Gella, F. Palomo, 1988, Enzyme.

Characterization of human serotonin 1D and 1B receptors using [ 3H]-GR-125743, a novel radiolabelled serotonin 5HT1D/1B receptor antagonist

J. Palacios, J. Palacios, J. Beleta, 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.